RESEARCH-USE BIOSIMILAR ANTIBODY
Sipavibart
Monoclonal antibody · IgG1
Sipavibart (AZD3152) is a human IgG1 λ2 monoclonal antibody against SARS-CoV-2. Sipavibart is applicable to research related to COVID-19. The isotype control product for Sipavibart is Human IgG1 lambda2, Isotype Control (HY-P990096).
TARGETSARS-CoV-2 Spike RBD
YMonoclonal antibody
CATALOGSC-BS-164
CATALOG NUMBERSC-BS-164
MOLECULAR WEIGHTApprox. 144.7 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Sipavibart (AZD3152) is a human IgG1 λ2 monoclonal antibody against SARS-CoV-2. Sipavibart is applicable to research related to COVID-19. The isotype control product for Sipavibart is Human IgG1 lambda2, Isotype Control (HY-P990096).
Sipavibart is a recombinant research-use antibody directed against SARS-CoV-2 Spike RBD.